Skip to main content
. 2022 Aug 12;14(8):1685. doi: 10.3390/pharmaceutics14081685

Figure 6.

Figure 6

(A) The effect of CHOL-LP and Dios-LP on HepG2 cells; (B) The effect of different concentrations of DOX, CHOL-DOX-LP, and Dios-DOX-LP on HepG2 cells.